tazarotene 0.45 MG/ML Topical Lotion [Arazlo]
tazarotene
RxCUI: 2267566
What the CMS Formulary Data Shows for tazarotene 0.45 MG/ML Topical Lotion [Arazlo]
Per the CMS 2026 Part D formulary file, tazarotene 0.45 MG/ML Topical Lotion [Arazlo] (RxNorm concept RXCUI 2267566, generic name tazarotene) appears on 3 distinct formulary files spanning 21 Medicare Part D plan offerings - 0.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.
Real-world access to tazarotene 0.45 MG/ML Topical Lotion [Arazlo] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,869 Part D beneficiaries filled tazarotene 0.45 MG/ML Topical Lotion [Arazlo] in 2023, with total plan-and-beneficiary spending of $2,710,202 and an average per-beneficiary annual cost of $556.62. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tazarotene 0.45 MG/ML Topical Lotion [Arazlo] today.
Coverage Details
- Formularies covering
- 3
- Plans covering
- 21
- Coverage rate
- 0.4%
- Tier range
- Tier 4, Non-Preferred
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,869
- Total spending
- $2,710,202
- Avg per beneficiary
- $556.62
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering tazarotene 0.45 MG/ML Topical Lotion [Arazlo]
21 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Medicare BlueEssential (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | EXCELLUS HEALTH PLAN COMMUNITY CARE LLC | T4 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | EXCELLUS HEALTH PLAN COMMUNITY CARE LLC | T4 | Yes | $0 | NY |
| CDPHP $0 Medicare Rx (HMO) | CAPITAL DISTRICT PHYSICIANS' HEALTH PLAN, INC. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Core (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $33.00 | NY |
| Univera SeniorChoice Advanced (HMO-POS) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $36.90 | NY |
| Medicare BlueClassic (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $51.00 | NY |
| Univera SeniorChoice Secure (HMO-POS) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $54.90 | NY |
| Medicare BlueBalanced (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $55.00 | NY |
| Medicare Blue Choice Prime (HMO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $55.00 | NY |
| Univera SeniorChoice Value Plus (HMO-POS) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $58.60 | NY |
| Medicare BlueEnhanced (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $70.30 | NY |
| Medicare BluePlus (PPO) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $86.40 | NY |
| CDPHP Clear Rx (HMO) | CAPITAL DISTRICT PHYSICIANS' HEALTH PLAN, INC. | T4 | Yes | $100.00 | NY |
| CDPHP Choice Rx (HMO) | CAPITAL DISTRICT PHYSICIANS' HEALTH PLAN, INC. | T4 | Yes | $135.00 | NY |
| Medicare Blue Choice Optimum (HMO-POS) | EXCELLUS HEALTH PLAN, INC. | T4 | Yes | $146.00 | NY |
Frequently Asked Questions
Is tazarotene 0.45 MG/ML Topical Lotion [Arazlo] covered by Medicare Part D?
Yes, tazarotene 0.45 MG/ML Topical Lotion [Arazlo] is covered by 21 Medicare Part D plans (0.4% of all Part D formularies).
What tier is tazarotene 0.45 MG/ML Topical Lotion [Arazlo] on Medicare Part D plans?
tazarotene 0.45 MG/ML Topical Lotion [Arazlo] averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.
Does tazarotene 0.45 MG/ML Topical Lotion [Arazlo] require prior authorization?
100% of Part D formularies require prior authorization for tazarotene 0.45 MG/ML Topical Lotion [Arazlo]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on tazarotene 0.45 MG/ML Topical Lotion [Arazlo]?
In 2023, total Medicare Part D spending on tazarotene 0.45 MG/ML Topical Lotion [Arazlo] was $2,710,202, covering 4,869 beneficiaries. The average spend per beneficiary was $556.62.
Read our methodology - how this data is sourced, computed, and verified.